Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial

J. Bjerggaard Jensen; K. Birkenkamp-Demtröder; I. Nordentoft; R.V. Milling; S.K. Körner; S.B. Brandt; M. Knudsen; G.W. Lam; L.H. Dohn; K. Fabrin; A. Carus; A. Petersen; U.N.  Joensen; H. Pappot; P.S. Holt; N.V. Jensen; M. Agerbæk; L. Dyrskjot

doi:10.1016/j.annonc.2024.08.2045

Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial

J. Bjerggaard Jensen, K. Birkenkamp-Demtröder, I. Nordentoft, R.V. Milling, S.K. Körner, S.B. Brandt, M. Knudsen, G.W. Lam, L.H. Dohn, K. Fabrin, A. Carus, A. Petersen, U.N. Joensen, H. Pappot, P.S. Holt, N.V. Jensen, M. Agerbæk, L. Dyrskjot

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Artikelnummer	1960O
Tidsskrift	Annals of Oncology
Vol/bind	35
Udgave nummer	Suppl. 2
Sider (fra-til)	S1133
Antal sider	1
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2024.08.2045
Status	Udgivet - sep. 2024
Begivenhed	ESMO Congress 2024 - Barcelona, Spanien Varighed: 13 sep. 2024 → 17 sep. 2024 https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024

Konference

Konference	ESMO Congress 2024
Land/Område	Spanien
By	Barcelona
Periode	13/09/2024 → 17/09/2024
Internetadresse	https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024

Bibliografisk note

Abstrakt No. 1960O

Adgang til dokumentet

10.1016/j.annonc.2024.08.2045

https://linkinghub.elsevier.com/retrieve/pii/S0923753424035646

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Bjerggaard Jensen, J., Birkenkamp-Demtröder, K., Nordentoft, I., Milling, R. V., Körner, S. K., Brandt, S. B., Knudsen, M., Lam, G. W., Dohn, L. H., Fabrin, K., Carus, A., Petersen, A., Joensen, U. N., Pappot, H., Holt, P. S., Jensen, N. V., Agerbæk, M., & Dyrskjot, L. (2024). Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial. Annals of Oncology, 35(Suppl. 2), S1133. Artikel 1960O. https://doi.org/10.1016/j.annonc.2024.08.2045

@article{a4383bf25d0d4d1ea0409f3ae85647d5,

title = "Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial",

author = "{Bjerggaard Jensen}, J. and K. Birkenkamp-Demtr{\"o}der and I. Nordentoft and R.V. Milling and S.K. K{\"o}rner and S.B. Brandt and M. Knudsen and G.W. Lam and L.H. Dohn and K. Fabrin and A. Carus and A. Petersen and U.N. Joensen and H. Pappot and P.S. Holt and N.V. Jensen and M. Agerb{\ae}k and L. Dyrskjot",

note = "Abstract No. 1960O; ESMO Congress 2024 ; Conference date: 13-09-2024 Through 17-09-2024",

year = "2024",

month = sep,

doi = "10.1016/j.annonc.2024.08.2045",

language = "English",

volume = "35",

pages = "S1133",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 2",

url = "https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024",

}

Bjerggaard Jensen, J, Birkenkamp-Demtröder, K, Nordentoft, I, Milling, RV, Körner, SK, Brandt, SB, Knudsen, M, Lam, GW, Dohn, LH, Fabrin, K , Carus, A , Petersen, A, Joensen, UN, Pappot, H, Holt, PS, Jensen, NV, Agerbæk, M & Dyrskjot, L 2024, 'Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial', Annals of Oncology, bind 35, nr. Suppl. 2, 1960O, s. S1133. https://doi.org/10.1016/j.annonc.2024.08.2045

Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial. / Bjerggaard Jensen, J.; Birkenkamp-Demtröder, K.; Nordentoft, I. et al.
I: Annals of Oncology, Bind 35, Nr. Suppl. 2, 1960O, 09.2024, s. S1133.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

TY - ABST

T1 - Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial

AU - Bjerggaard Jensen, J.

AU - Birkenkamp-Demtröder, K.

AU - Nordentoft, I.

AU - Milling, R.V.

AU - Körner, S.K.

AU - Brandt, S.B.

AU - Knudsen, M.

AU - Lam, G.W.

AU - Dohn, L.H.

AU - Fabrin, K.

AU - Carus, A.

AU - Petersen, A.

AU - Joensen, U.N.

AU - Pappot, H.

AU - Holt, P.S.

AU - Jensen, N.V.

AU - Agerbæk, M.

AU - Dyrskjot, L.

N1 - Abstract No. 1960O

PY - 2024/9

Y1 - 2024/9

U2 - 10.1016/j.annonc.2024.08.2045

DO - 10.1016/j.annonc.2024.08.2045

M3 - Conference abstract in journal

SN - 0923-7534

VL - 35

SP - S1133

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 2

M1 - 1960O

T2 - ESMO Congress 2024

Y2 - 13 September 2024 through 17 September 2024

ER -

Bjerggaard Jensen J, Birkenkamp-Demtröder K, Nordentoft I, Milling RV, Körner SK, Brandt SB et al. Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial. Annals of Oncology. 2024 sep.;35(Suppl. 2):S1133. 1960O. doi: 10.1016/j.annonc.2024.08.2045